DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Fuzhenghuayu
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
93
原発性胆汁性胆管炎
2
93. 原発性胆汁性胆管炎
臨床試験数
:
298
/
薬物数
:
252
- (
DrugBank
:
59
) /
標的遺伝子数
:
35
-
標的パスウェイ数
:
115
10
50
100
ALL
trials per page:
Showing 1 to 2 of 2 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02916290
(
ClinicalTrials.gov
)
January 2016
20160100
28/1/2016
20160128
Fuzhenghuayu
in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Primary Biliary Cirrhosis
Drug:
Fuzhenghuayu
;Drug: UDCA
Xijing Hospital of Digestive Diseases
NULL
Recruiting
18 Years
70 Years
Both
200
Phase 3
China
2
NCT02916641
(
ClinicalTrials.gov
)
January 2016
20160100
28/1/2016
20160128
Fuzhenghuayu
for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
Primary Biliary Cirrhosis
Drug:
Fuzhenghuayu
;Drug: UDCA
Xijing Hospital of Digestive Diseases
NULL
Recruiting
18 Years
70 Years
Both
200
Phase 3
China